Meta‐Research on Oncology Trials: A Toolkit for Researchers with Limited Resources

por Riechelmann, Rachel P., Péron, Julien, Seruga, Bostjan, Saad, Everardo D.
Publicado en Oncologist (2018)

Methods and Designs of Modern Breast Cancer Confirmatory Trials

por Péron, Julien, Reverdy, Thibaut, Smenteck, Colette, Cortet, Marion, You, Benoît, Freyer, Gilles
Publicado en Cancers (Basel) (2021)

Changes in the Use of Comprehensive Geriatric Assessment in Clinical Trials for Older Patients with Cancer over Time

por Le Saux, Olivia, Falandry, Claire, Gan, Hui K., You, Benoit, Freyer, Gilles, Péron, Julien
Publicado en Oncologist (2019)

Access to Clinical Trials for Adolescents and Young Adults With Cancer: A Meta-Research Analysis

por de Rojas, Teresa, Neven, Anouk, Terada, Mitsumi, García-Abós, Miriam, Moreno, Lucas, Gaspar, Nathalie, Péron, Julien
Publicado en JNCI Cancer Spectr (2019)

An effective and well-tolerated strategy in recurrent and/or metastatic head and neck cancer: successive lines of active chemotherapeutic agents

por Péron, Julien, Polivka, Valentine, Chabaud, Sylvie, Poupart, Marc, Ceruse, Philippe, Ramade, Antoine, Girodet, Didier, Zrounba, Philippe, Fayette, Jérôme
Publicado 2014

Association of Immunotherapy With Overall Survival in Elderly Patients With Melanoma

por Perier-Muzet, Marie, Gatt, Elodie, Péron, Julien, Falandry, Claire, Amini-Adlé, Mona, Thomas, Luc, Dalle, Stephane, Boespflug, Amelie
Publicado en JAMA Dermatol (2017)

Front-Line Maintenance Therapy in Advanced Ovarian Cancer—Current Advances and Perspectives

por Reverdy, Thibaut, Sajous, Christophe, Péron, Julien, Glehen, Olivier, Bakrin, Naoual, Gertych, Witold, Lopez, Jonathan, You, Benoit, Freyer, Gilles
Publicado en Cancers (Basel) (2020)

Bevacizumab for Newly Diagnosed Ovarian Cancers: Best Candidates Among High-Risk Disease Patients (ICON-7)

por Colomban, Olivier, Tod, Michel, Peron, Julien, Perren, Timothy J, Leary, Alexandra, Cook, Adrian D, Sajous, Christophe, Freyer, Gilles, You, Benoit
Publicado en JNCI Cancer Spectr (2020)

An assessment of the benefit-risk balance of FOLFIRINOX in metastatic pancreatic adenocarcinoma

por Péron, Julien, Roy, Pascal, Conroy, Thierry, Desseigne, Françoise, Ychou, Marc, Gourgou-Bourgade, Sophie, Stanbury, Trevor, Roche, Laurent, Ozenne, Brice, Buyse, Marc
Publicado en Oncotarget (2016)

Assessing Long-Term Survival Benefits of Immune Checkpoint Inhibitors Using the Net Survival Benefit

por Péron, Julien, Lambert, Alexandre, Munier, Stephane, Ozenne, Brice, Giai, Joris, Roy, Pascal, Dalle, Stéphane, Machingura, Abigirl, Maucort-Boulch, Delphine, Buyse, Marc
Publicado en J Natl Cancer Inst (2019)

Developing a Return to Work Intervention for Breast Cancer Survivors with the Intervention Mapping Protocol: Challenges and Opportunities of the Needs Assessment

por Fassier, Jean-Baptiste, Lamort-Bouché, Marion, Broc, Guillaume, Guittard, Laure, Péron, Julien, Rouat, Sabrina, Carretier, Julien, Fervers, Béatrice, Letrilliart, Laurent, Sarnin, Philippe
Publicado en Front Public Health (2018)

Neoadjuvant modified TPF (docetaxel, cisplatin, fluorouracil) for patients unfit to standard TPF in locally advanced head and neck squamous cell carcinoma: a study of 48 patients

por Fayette, Jérôme, Fontaine-Delaruelle, Clara, Ambrun, Alexis, Daveau, Clémentine, Poupart, Marc, Ramade, Antoine, Zrounba, Philippe, Neidhardt, Eve-Marie, Péron, Julien, Diallo, Alpha, Céruse, Philippe
Publicado en Oncotarget (2016)

Antibiotics against Pseudomonas aeruginosa for COPD exacerbation in ICU: a 10-year retrospective study

por Planquette, Benjamin, Péron, Julien, Dubuisson, Etienne, Roujansky, Ariane, Laurent, Virginie, Le Monnier, Alban, Legriel, Stephane, Ferre, Alexis, Bruneel, Fabrice, Chiles, Peter G, Bedos, Jean P
Publicado en Int J Chron Obstruct Pulmon Dis (2015)

Investigating the Impact of Immune-Related Adverse Events, Glucocorticoid Use and Immunotherapy Interruption on Long-Term Survival Outcomes

por de la Bruyère, Charline Lafayolle, Souquet, Pierre-Jean, Dalle, Stéphane, Corbaux, Pauline, Boespflug, Amélie, Duruisseaux, Michaël, Kiakouama-Maleka, Lize, Reverdy, Thibaut, Maugeais, Madeleine, Sahin, Gulsum, Maillet, Denis, Péron, Julien
Publicado en Cancers (Basel) (2021)

Publisher Correction: Clinical outcome of breast cancer in carriers of BRCA1 and BRCA2 mutations according to molecular subtypes

por De Talhouet, Solene, Peron, Julien, Vuilleumier, Aurelie, Friedlaender, Alex, Viassolo, Valeria, Ayme, Aurélie, Bodmer, Alexandre, Treilleux, Isabelle, Lang, Noemie, Tille, Jean-Christophe, Chappuis, Pierre O., Buisson, Adrien, Giraud, Sophie, Lasset, Christine, Bonadona, Valerie, Trédan, Olivier, Labidi-Galy, S. Intidhar
Publicado en Sci Rep (2020)

Clinical outcome of breast cancer in carriers of BRCA1 and BRCA2 mutations according to molecular subtypes

por Talhouet, Solene De, Peron, Julien, Vuilleumier, Aurelie, Friedlaender, Alex, Viassolo, Valeria, Ayme, Aurélie, Bodmer, Alexandre, Treilleux, Isabelle, Lang, Noemie, Tille, Jean- Christophe, Chappuis, Pierre O., Buisson, Adrien, Giraud, Sophie, Lasset, Christine, Bonadona, Valerie, Trédan, Olivier, Labidi-Galy, S.Intidhar
Publicado en Sci Rep (2020)